Profile: Rockland Technimed Limited specializes in offering oxygen metabolic imaging agents. Oxy-17® are oxygen metabolic imaging agents (TVI-agents) which are injected intravenously prior to imaging in a standard MRI scanner. They track oxygen metabolism at the cellular level in the region of interest at 1 mm resolution with a time course that renders it ideal for several clinical indications. Clinical applications of these are significant in the measurement of oxygen uptake (OEF/R), of heart, brain, viscera, and transplant. Oxy-17® may also be useful to study the brain tissue oxygen uptake (OEF/R), in epilepsy for foci localization. in-situ tissue regeneration (tissue engineering) including the effects of newly formulated therapeutics.

The company was founded in 1999, has revenues of < USD 1 Million, has ~10 employees.